BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morris A, Fitzpatrick M, Bertolet M, Qin S, Kingsley L, Leo N, Kessinger C, Michael H, Mcmahon D, Weinman R, Stone S, Leader JK, Kleerup E, Huang L, Wisniewski SR. Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease. AIDS 2017;31:539-44. [PMID: 27941393 DOI: 10.1097/QAD.0000000000001365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 MacDonald DM, Collins G, Wendt CH, Wolfson J, Tracy RP, Rhame F, Deeks S, Rizza SA, Temesgen Z, Morse C, Liappis AP, Sereti I, Baker JV, Kunisaki KM. Short Communication: A Pilot Study of the Effects of Losartan Versus Placebo on Pneumoproteins in HIV: A Secondary Analysis of a Randomized Double Blind Study. AIDS Res Hum Retroviruses 2022;38:127-30. [PMID: 33749317 DOI: 10.1089/AID.2020.0285] [Reference Citation Analysis]
2 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chandra D, Gupta A, Fitzpatrick M, Haberlen SA, Neupane M, Leader JK, Kingsley LA, Kleerup E, Budoff MJ, Witt M, Sciurba FC, Post WS, Morris A. Lung Function, Coronary Artery Disease, and Mortality in HIV. Ann Am Thorac Soc 2019;16:687-97. [PMID: 31113229 DOI: 10.1513/AnnalsATS.201807-460OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Singhvi D, Bon J, Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis. Curr HIV/AIDS Rep 2019;16:359-69. [PMID: 31256349 DOI: 10.1007/s11904-019-00456-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
5 Li Y, Nouraie SM, Kessinger C, Weinman R, Huang L, Greenblatt RM, Kleerup E, Kingsley L, McMahon D, Fitzpatrick M, Morris A. Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals. J Acquir Immune Defic Syndr 2018;79:501-9. [PMID: 30142142 DOI: 10.1097/QAI.0000000000001840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Walsh A, Perrem L, Khashan AS, Henry MT, Ni Chroinin M. Statins versus placebo for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2019;7:CD011959. [PMID: 31425628 DOI: 10.1002/14651858.CD011959.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS 2018;32:277-92. [PMID: 29194119 DOI: 10.1097/QAD.0000000000001712] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]